10.1016/0024-3205(88)90124-5 Pubmed Abstract CrossRef Google Scholar View reference in article 22
Bartter syndrome (BS) BS is like Gitelman syndrome characterized by hypokalemic alkalosis, hypomagnesemia but with hyperreninemic hyperaldosteronemia and normal blood pressure
Ozer F, Meral H, Hanoglu L et al (2006) Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations
The TIMP was added solely based on the concerns raised by the IRB, and this motor test will mainly be used as a tool for the DSMB when deciding whether the study should continue or not
Disclosures: Alejandra Villamil: Novartis: Advisor, Ziad Younes: Intercept: Grant/Research Support, intercept: Consultant, intercept: Speaking and Teaching, Madrigal: Speaking and Teaching, Madrigal: Consultant, Madrigal: Grant/Research Support, cymabay: Grant/Research Support, cymabay: Consultant, ipsen: Grant/Research Support, Inventiva: Grant/Research Support, Poxel: Grant/Research Support, Altimmune: Grant/Research Support, NST: Grant/Research Support, NGM Bio: Grant/Research Support, 89Bio: Grant/Research Support, Helio: Grant/Research Support, Exact Sciences: Grant/Research Support, Corcept: Grant/Research Support, Galectin: Grant/Research Support, AstraZeneca: Grant/Research Support, Christopher Bowlus: Calliditas: Grant/Research Support, ChemoMab: Grant/Research Support, ChemoMab: Consultant, COUR Phamaceuticals: Grant/Research Support, Cymabay: Grant/Research Support, Cymabay: Consultant, Cymabay: Consultant, Gilead: Grant/Research Support, GSK Pharmaceuticals: Grant/Research Support, GSK Pharmaceuticals: Consultant, Hanmi: Grant/Research Support, Intercept: Grant/Research Support, Invea Therapeutics: Consultant, Ipsen: Grant/Research Support, Ipsen: Consultant, Mirum: Grant/Research Support, NGM Bio: Consultant, Novartis: Grant/Research Support, Novo Nordisk: Grant/Research Support, Pliant Therapeutics: Grant/Research Support, Pliant Therapeutics: Consultant, Viking Therapeutics: Grant/Research Support, Zydus Therapeutics: Grant/Research Support, John Vierling: Nothing to Disclose, Adam Vasura: Nothing to Disclose, Andrea Galli: Nothing to Disclose, Mordechai Rabinovitz: Nothing to Disclose, Frederik Nevens: Nothing to Disclose, Susheela Carroll: CymaBay Therapeutics: Employee, Calithera Biosciences: Employee, Ke Yang: Nothing to Disclose, Daria Crittenden: Nothing to Disclose, Charles McWherter: Nothing to Disclose, Eric Lawitz: Nothing to Disclose 701 ENDURANCE EXERCISE PROMOTES FAVORABLE GUT MICROBIOME COMPOSITION DURING HYPERAMMONEMIA Annette Bellar 1 Nasser Sangwan 1 Avinash Kumar 2 Muaz Alsabbagh Alchirazi 1 Pugazhendhi Kannan 1 Amy Attaway 1 Saurabh Mishra 1 Nicole Welch 1 Srinivasan Dasarathy 1 , 1 Cleveland Clinic, 2 All India Institute of Medical Sciences Background: Endurance exercise (EE) promotes a favorable gut microbiome (GMB) that includes generation of short chain fatty acid (SCFA)
